---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-165631"
form_type: "8-K"
ticker: "QNCX"
cik: "0001662774"
company_name: "Quince Therapeutics, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:52:41.166496+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Quince Therapeutics receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Received Nasdaq notice for non-compliance with $1.00 minimum bid price requirement.
- Closing bid price below $1.00 for 34 consecutive trading days.
- Has until December 17, 2024 to regain compliance by closing at $1.00 for 10 consecutive days.
- May transfer to Nasdaq Capital Market for additional 180-day compliance period if eligible.
- Company will monitor closing bid price; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001193125-24-165631
- form_type: 8-K
- ticker: QNCX
- cik: 0001662774
- company_name: Quince Therapeutics, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662774/000119312524165631/0001193125-24-165631-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662774/000119312524165631/d835941d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-165631
- JSON: https://secwatch.observer/filing/0001193125-24-165631.json
- Plain text: https://secwatch.observer/filing/0001193125-24-165631.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.